| Crystal Structure of Human ALKBH5 | | monomer | 69-292 | 100.0 | 1×MN; 1×NO3; 2×GOL; 1×UN9; |
|
| Crystal structure of human ALKBH5 in complex with citrate and acetate | | monomer | 73-292 | 100.0 | 1×FLC; 1×ACT; |
|
| Crystal structure of human ALKBH5 in complex with alpha-ketoglutarate | | monomer | 73-292 | 100.0 | 1×MN; 1×AKG; |
|
| Crystal structure of human ALKBH5 in complex with pyridine-2,4-dicarboxylate | | monomer | 73-292 | 100.0 | 1×PD2; 1×MN; |
|
| Crystal structure of human ALKBH5 in complex with Mn2+ | | monomer | 74-292 | 100.0 | 1×MN; |
|
| Crystal structure of human ALKBH5 in complex with N-oxalylglycine | | monomer | 74-292 | 100.0 | 1×MN; 1×OGA; |
|
| Structure of human ALKBH5 crystallized in the presence of citrate | | monomer | 76-294 | 100.0 | 1×GOL; 1×CIT; 1×UNL; 15×UNX; |
|
| Crystal structure of human ALKBH5 in complex with 2-oxoglutarate (2OG) and m6A-containing ssRNA | | monomer | 74-292 | 100 | 1×MN; 1×AKG; |
|
| Crystal structure of human ALKBH5 crystallized in the presence of Mn^{2+} and 2-oxoglutarate | | monomer | 77-293 | 100.0 | 1×MN; 1×AKG; 9×UNX; |
|
| Crystal structure of human ALKBH5 in complex with N-oxalylglycine (NOG) and m6A-containing ssRNA | | monomer | 79-292 | 100 | 1×MN; 1×OGA; |
|
| Crystal structure of human ALKBH5 in complex with m6A-containing ssRNA | | monomer | 81-292 | 100 | 2×GOL; 1×MN; 1×SO4; |
|